Onkologie. 2019:13(5):195-200 | DOI: 10.36290/xon.2019.037

Surgical treatment of urinary bladder cancer

Otakar Čapoun
Urologická klinika VFN a 1. LF UK v Praze

Diagnosis and primary treatment of bladder tumors involve careful transurethral resection. Histology specifies tumor type, grading and depth of invasion into the wall of bladder. Based on the latter, tumors divide into non–muscle–invasive and muscle–invasive. There are four main risk groups of non–muscle–invasive tumors. According to them, the monitoring or intravesical chemotherapy or immunotherapy are indicated. Early radical cystectomy (RC) should be performed in the highest risk group. The surgical approach for invasive tumors includes RC, pelvic lymphadenectomy and urinary diversion, most often in the ureteroileostomy or orthotopic neobladder. Complications after RC are frequent and depend largely on the experience of a surgeon and the number of cases at an individual centre.

Keywords: bladder tumors, transurethral resection, radical cystectomy, complications

Published: October 20, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čapoun O. Surgical treatment of urinary bladder cancer. Onkologie. 2019;13(5):195-200. doi: 10.36290/xon.2019.037.
Download citation

References

  1. Mužík J, Dušek L, Babjuk M, Kubásek M, Fínek J, Petruželka L. Uroweb - webový portál pro analýzu a vizualizaci epidemiologie, diagnostiky a léčby urologických malignit [online]. Masarykova univerzita, Brno, 2019. Přístup 29. 8. 2019. Dostupný z: http://www.uroweb.cz.
  2. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol. 2006; 49(3): 466-465; discussion 475-477. Go to original source... Go to PubMed...
  3. Babjuk M, Burger M, Compérat EM, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. Eur Urol. 2019 Aug 20. V tisku. Přístup dne 29. 8. 2019. Dostupný z: https://doi.org/10.1016/j.eururo.2019.08.016. Go to original source... Go to PubMed...
  4. Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol. 2017; 71(3): 462-475. Go to original source... Go to PubMed...
  5. van der Meijden A, Oosterlinck W, Brausi M, et al. Significance of bladder biopsies in Ta,T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol. 1999; 35(4): 267-271. Go to original source... Go to PubMed...
  6. Palou J, Sylvester RJ, Faba OR, et al. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin. Eur Urol. 2012; 62(1): 118-125. Go to original source... Go to PubMed...
  7. Zhao C, Tang K, Yang H, Xia D, Chen Z. Bipolar Versus Monopolar Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: A Meta-Analysis. J Endourol. 2016;30(1):5-12. Go to original source... Go to PubMed...
  8. Kramer MW, Altieri V, Hurle R. Current, et al. Evidence of Transurethral En-bloc Resection of Nonmuscle Invasive Bladder Cancer. Eur Urol Focus. 2017; 3(6): 567-576. Go to original source... Go to PubMed...
  9. Chou R, Selph S, Buckley DI, et al. Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta-Analysis. J Urol. 2017; 197(3 Pt 1): 548-558. Go to original source... Go to PubMed...
  10. Naito S, Algaba F, Babjuk M, et al. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results. Eur Urol. 2016; 70(3): 506-515. Go to original source... Go to PubMed...
  11. Cumberbatch MGK, Foerster B, Catto JWF, et al. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review. Eur Urol. 2018; 73(6): 925-933. Go to original source... Go to PubMed...
  12. Cornu JN, Herrmann T, Traxer O, Matlaga B. Prevention and Management Following Complications from Endourology Procedures. Eur Urol Focus. 2016; 2(1): 49-59. Go to original source... Go to PubMed...
  13. http://www.cus.cz/pro-odborniky/aktuality/nedostupnost-bcg-vakciny-na-nasem-trhu/. Přístup dne 30. 8. 2019.
  14. Haden TD, Prunty MC, Jones AB, Deroche CB, et al. Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer-Do Outcomes Differ? Eur Urol Focus. 2018; 4(6): 895-899. Go to original source... Go to PubMed...
  15. Ayres BE, Gillatt D, McPhail S, Cottrell A, et al. A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int. 2008; 102(8):1045. Go to original source... Go to PubMed...
  16. Zehnder P, Studer UE, Skinner EC, et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol. 2011; 186(4): 1261-1268. Go to original source... Go to PubMed...
  17. Novara G, Catto JW, Wilson T, et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol. 2015; 67(3): 376-401. Go to original source... Go to PubMed...
  18. Madersbacher S, Schmidt J, Eberle JM, et al. Long-term outcome of ileal conduit diversion. J Urol. 2003;169(3):985-90. Go to original source... Go to PubMed...
  19. Karl A, Buchner A, Becker A, et al. A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol. 2014; 191(2): 335-340. Go to original source... Go to PubMed...
  20. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001; 19(3): 666-675. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.